Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Photodermatol Photoimmunol Photomed ; 40(1): e12943, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38288770

RESUMEN

BACKGROUND: The human skin microbiome is a dynamic ecosystem that plays an important role in skin health. The skin microbiome has been implicated in numerous diseases, and our knowledge surrounding it continues to evolve. A better understanding of the interactions between the environment and the skin microbiome will lead to improvements in skin health. METHODS: This article reviews the published literature surrounding the impact of ultraviolet radiation (UVR) and sunscreen on the skin microbiome. RESULTS: Skin microbes are differentially impacted by UVR, and alterations in the microbiome can be detected following UVR exposure. These changes are related to direct bactericidal effects, alterations in the cutaneous metabolome, and changes in the cutaneous immune system. UV filters used in sunscreen have been shown to have bactericidal effects, and many compounds used in sunscreen emulsions can also negatively impact cutaneous microbes. CONCLUSION: A healthy microbiome has been shown to produce compounds that help protect the skin from UVR, and sunscreen has the potential to reduce the diversity of the skin microbiome. This indicates that designing sunscreen products that both provide protection against UVR and preserve the skin microbiome may offer additional benefits to skin health when compared with traditional sunscreen products.


Asunto(s)
Protectores Solares , Rayos Ultravioleta , Humanos , Protectores Solares/farmacología , Rayos Ultravioleta/efectos adversos , Ecosistema , Piel/efectos de la radiación
2.
Photochem Photobiol Sci ; 22(10): 2463-2471, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37344707

RESUMEN

Sunscreens are an important means of protection against sunburns, dyspigmentation, photoaging, and photocarcinogenesis. Sunscreens come in a variety of formulations that can protect against ultraviolet B (UVB) radiation, both UVB and ultraviolet A (UVA) radiation (broad-spectrum sunscreens), and UVB, UVA, and visible light (tinted broad-spectrum sunscreens). In the USA, there is currently a paucity of FDA-approved broad-spectrum filters on the market. Studies have identified the presence of multiple UV filters in water sources globally. Many laboratory studies have implicated the potential impact of UV filters on coral reef bleaching, the food chain, and human health. However, many of these studies are performed at concentrations that are much higher than those present in the natural environment. With increasing discussion surrounding the role of organic and inorganic UV filters as potential environmental pollutants over the past decade, approval of additional broad-spectrum filters would be an important means of alleviating the use of more controversial filters. The aim of this article is to review the effects of UV filters on health and the environment and explore potential adjunctive agents for photoprotection.


Asunto(s)
Quemadura Solar , Protectores Solares , Humanos , Protectores Solares/farmacología , Protectores Solares/uso terapéutico , Quemadura Solar/prevención & control , Rayos Ultravioleta , Piel/efectos de la radiación
3.
J Am Acad Dermatol ; 88(2): 291-320, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-35158001

RESUMEN

Key challenges in the management of pigmentary disorders such as melasma and postinflammatory hyperpigmentation are their resistance to treatment, tendency to recur after treatment, and the risk of exacerbating hyperpigmentation with many treatment modalities. The second article in this 2-part continuing medical education series on pigmentary disorders focuses on the evidence behind medical and procedural treatments of dyschromias, including photoprotection, topical lightening agents, oral agents, chemical peels, and laser therapy.


Asunto(s)
Quimioexfoliación , Hiperpigmentación , Terapia por Láser , Terapia por Luz de Baja Intensidad , Melanosis , Humanos , Hiperpigmentación/terapia , Hiperpigmentación/prevención & control , Melanosis/terapia , Resultado del Tratamiento
4.
J Am Acad Dermatol ; 88(2): 271-288, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-35151757

RESUMEN

Disorders of hyperpigmentation are common and, depending on the extent and location of involvement, can affect the quality of life and pose a significant psychologic burden for patients. Given the similarities in presentation of the various causes of hyperpigmentation, it is often difficult to elucidate the etiology of these conditions, which is important to guide management. Furthermore, certain disorders, such as lichen planus pigmentosus and ashy dermatosis, have similar clinical and/or histologic presentations, and their classification as distinct entities has been debated upon, leading to additional confusion. In this review, the authors selected commonly encountered disorders of hyperpigmentation of the skin, subdivided into epidermal, dermal, or mixed epidermal-dermal disorders based on the location of pigment deposition, along with disorders of hyperpigmentation of the mucosa and nails. Melanocytic nevi, genetic disorders, and systemic causes of hyperpigmentation were largely excluded and considered to be outside the scope of this review. We discussed the pathogenesis of hyperpigmentation as well as the clinical and histologic features of these conditions, along with challenges encountered in their diagnosis and classification. The second article in this 2-part continuing medical education series focuses on the medical and procedural treatments of hyperpigmentation.


Asunto(s)
Hiperpigmentación , Liquen Plano , Neoplasias Cutáneas , Humanos , Calidad de Vida , Hiperpigmentación/diagnóstico , Hiperpigmentación/etiología , Hiperpigmentación/terapia , Piel/patología , Liquen Plano/complicaciones , Neoplasias Cutáneas/patología
5.
Dermatology ; 239(5): 828-831, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37231873

RESUMEN

BACKGROUND: The autologous noncultured melanocyte keratinocyte transplant procedure (MKTP) has emerged as a popular grafting technique with proven efficacy for achieving repigmentation. However, there remains no consensus regarding the optimal recipient-to-donor (RD) ratio required to achieve acceptable repigmentation. In this retrospective cohort study of 120 patients, we sought to examine whether expansion ratios impact the repigmentation success rates following MKTP. RESULTS: A total of 69 patients (mean [SD] age was 32.4 [14.3] years, mean follow-up was 30.4 [22.5] months, 63.8% were male; 55% were dark-skinned individuals [Fitzpatrick IV-VI]) were included. The mean percent change in the Vitiligo Area Scoring Index (VASI) was 80.2 (±23.7; RD of 7.3) in patients with focal/segmental vitiligo (SV), 58.3 (±33.0; RD of 8.2) in those with non-segmental vitiligo (NSV), and 51.8 (±33.6; RD of 3.7) in those with leukoderma and piebaldism. Focal/SV was positively associated with a higher percent change in VASI (parameter estimate: 22.6, p value <0.005). In the SV/focal group, non-white patients had a higher RD ratio compared to White individuals (8.2 ± 3.4 vs. 6.0 ± 3.1, respectively, p value = 0.035). DISCUSSION: In our study, we found that patients with SV were significantly more likely to achieve higher repigmentation rates compared to those with NSV. Although repigmentation rates were higher in the low expansion ratio group than in the high expansion ratio group, we did not observe a significant difference between the two groups. CONCLUSION: MKTP is an effective therapy for restoring repigmentation in patients with stable vitiligo. Therapeutic response of vitiligo to MKTP appears to be influenced by the type of vitiligo, rather than a specific RD ratio.


Asunto(s)
Trasplante de Células , Queratinocitos , Melanocitos , Piebaldismo , Vitíligo , Adolescente , Femenino , Humanos , Masculino , Queratinocitos/trasplante , Melanocitos/trasplante , Piebaldismo/cirugía , Estudios Retrospectivos , Resultado del Tratamiento , Vitíligo/cirugía , Trasplante Autólogo , Adulto Joven , Adulto
6.
Photodermatol Photoimmunol Photomed ; 39(2): 93-99, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36655819

RESUMEN

INTRODUCTION: Polymorphous light eruption (PMLE) and chronic actinic dermatitis (CAD) have been classically described in White individuals, although recent studies have reported higher prevalence in patients with dark skin types, particularly African Americans. OBJECTIVE: To evaluate for differences in demographic, and clinical features between persons with light and dark skin types who have PMLE and CAD. METHODS: Retrospective review of patients with PMLE and CAD who were diagnosed from January 1, 1998, through November 31, 2021, at a single academic dermatology center. RESULTS/DISCUSSION: A total of 844 patients (725 [85.9%] female; mean [SD] age of onset: 41.7 [16.9] years) were diagnosed with PMLE, and 60 patients (22 [36.6%] female; mean age, [SD]: 60.6 [10.6] years) of age at presentation, disease duration of 8.2 [7.3] years were diagnosed with CAD. Although just over 50% of the general clinic population was White, the prevalence of PMLE and CAD was significantly higher in dark-skinned individuals compared to light-skinned individuals (PMLE: 625 [74.0%] vs. 219 [25.9%], p value < .001; CAD: 43 [71.6%] vs. 17 [28.3%], p value = .003) respectively. The pinpoint papular variant of PMLE (PP-PMLE) was predominantly seen in dark-skinned individuals. CONCLUSION: A substantial proportion of PMLE and CAD cases are present in dark-skinned individuals. PP-PMLE can be mistaken for lichen nitidus. As such, recognition of this entity is important for adequate evaluation and management of patients with PMLE.


Asunto(s)
Dermatitis por Contacto , Trastornos por Fotosensibilidad , Femenino , Humanos , Masculino , Negro o Afroamericano , Dermatitis por Contacto/epidemiología , Trastornos por Fotosensibilidad/epidemiología , Prevalencia , Adulto , Persona de Mediana Edad , Anciano , Pigmentación de la Piel
7.
Br J Dermatol ; 187(6): 1003-1004, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-35996818

RESUMEN

Currently, there is little guidance in the literature on how to advise patients who wear the hijab on hijab-related dermatoses. This manuscript describes hijab-related dermatoses and provides culturally sensitive recommendations that can be used in conjunction with standard treatments to provide more holistic care for these patients.


Asunto(s)
Islamismo , Enfermedades de la Piel , Humanos , Femenino , Vestuario , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/terapia
8.
Photodermatol Photoimmunol Photomed ; 38(5): 478-488, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35073443

RESUMEN

Clothing is recognized by leading health agencies as a primary method to protect against the harmful effects of photodamage caused by ultraviolet (UV) radiation and visible light. The photoprotective capacity of clothing is commonly measured as the ultraviolet protective factor (UPF). While the technology driving photoprotective clothing has been well-established, there continues to be efforts to discover new materials to improve the UPF of clothing. Here, we show increased Google searches for photoprotective clothing over the last decade, suggesting a high level of public interest in photoprotective clothing. In addition, we investigate the frequency of UPF-graded photoprotective clothing sold by large retail stores featured in Fortune 1000. We review factors that alter the UPF of clothing and describe emerging textile technologies used to increase clothing's photoprotective capacity. Finally, we compare how photoprotective clothing is regulated among different countries, the importance of photoprotective clothing in occupational health, and research in visible light and clothing photoprotection.


Asunto(s)
Ropa de Protección , Rayos Ultravioleta , Humanos , Textiles , Rayos Ultravioleta/efectos adversos
9.
Photodermatol Photoimmunol Photomed ; 36(3): 233-240, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32104953

RESUMEN

BACKGROUND: Previous studies at single academic institutions have identified variations in the prevalence of photodermatoses among racial groups. The purpose of the study was to compare the distribution of photodermatoses between Whites and Blacks at four academic medical centers in the USA. METHODS: A retrospective chart review was performed at four institutions' general dermatology clinics using diagnoses consistent with the International Classification of Disease (ICD), Ninth and Tenth Revisions, codes related to photodermatoses between August 2006 and August 2016. A total of 9736 charts were manually reviewed and classified. Analyses were performed analyzing the frequency of photodermatoses between Whites and Blacks in the pooled data. RESULTS: There were 1,080 patients with photodermatoses identified. Statistically significant differences in the frequency of photodermatoses between Whites and Blacks were identified for polymorphous light eruption (more common in Blacks), photoallergic contact dermatitis, phototoxic drug eruption, phytophotodermatitis, porphyria, and solar urticaria (more common in Whites). The most commonly diagnosed photodermatoses were polymorphous light eruption (total 672), and photodermatitis not otherwise specified (total 189). CONCLUSION: Our study demonstrated significantly higher proportions of polymorphous light eruption in Blacks, and higher proportions of photoallergic contact dermatitis, phototoxic drug eruptions, phytophotodermatitis, porphyrias, and solar urticaria in Whites.


Asunto(s)
Negro o Afroamericano/estadística & datos numéricos , Trastornos por Fotosensibilidad/etnología , Población Blanca/estadística & datos numéricos , Centros Médicos Académicos , Dermatitis Fotoalérgica/etnología , Dermatitis Fototóxica/etnología , Dermatología , Humanos , Servicio Ambulatorio en Hospital , Porfirias/etnología , Estudios Retrospectivos , Luz Solar/efectos adversos , Estados Unidos/epidemiología , Urticaria/etnología , Urticaria/etiología
12.
Photodermatol Photoimmunol Photomed ; 35(6): 393-399, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31152612

RESUMEN

Solar radiation is a major contributor to the development of skin cancer. Recent studies have shown that visible light (VL), a major portion of solar spectrum, induces biologic effects on the skin. Ultraviolet filters in currently available broad-spectrum sunscreens do not offer protection against VL. This study was designed to identify the spectral characteristics of the skin responses induced by VL, which can be utilized for time efficient in vivo VL testing. Thirty-one subjects were irradiated with a light source emitting visible light with less than 0.5% long wavelength UVA1 (VL + UVA1, 370-700 nm), and 41 subjects were irradiated with pure visible light (pure VL, 400-700 nm). Assessments including clinical photography, investigator's global assessment of pigmentation and erythema, and diffuse reflectance spectroscopy (DRS) performed immediately and seven days after irradiation. Clinical and spectroscopic data showed that VL + UVA1 spectral output induced significantly darker and persistent skin responses as compared to those induced by pure VL. Spectroscopic signatures of skin responses induced by both radiation sources were identified. The signatures were found to be specific to the radiation source and time of collection. A method to evaluate VL protection factor, using quantitative information from the spectral signatures obtained, was proposed.


Asunto(s)
Eritema/etiología , Luz/efectos adversos , Procesamiento de Señales Asistido por Computador , Pigmentación de la Piel/efectos de la radiación , Área Bajo la Curva , Femenino , Humanos , Masculino , Conceptos Matemáticos , Fotograbar , Piel/efectos de la radiación , Protectores Solares , Rayos Ultravioleta/efectos adversos
14.
J Drugs Dermatol ; 18(12): 1198-1203, 2019 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-31859468

RESUMEN

BACKGROUND: Visible light (VL) has multiple effects on the skin that currently available sunscreens do not protect against. Polypodium leucotomos extract (PLE) has properties that may offer protection against VL. OBJECTIVES: To determine the effectiveness of PLE in preventing VL-induced effects. METHODS: Twenty-two subjects with Fitzpatrick skin phototype IV-VI were enrolled. On day 0, subjects were irradiated with VL. Clinical Investigator's Global Assessment (IGA) scoring and spectroscopic evaluations were performed immediately, 24 hours, and 7 days after irradiation. Subjects then received a 28-day supply of PLE (480 mg daily). Irradiation and evaluation were repeated. Three 4-mm punch biopsies were obtained for immunohistochemistry analysis: one from normal unirradiated skin and the other two twenty-four hours after irradiation, pre- and post-PLE, from sites irradiated with highest dose of VL. RESULTS: All subjects had immediate pigment darkening, persistent pigment darkening, and delayed tanning both pre- and post-PLE. For the highest VL dose (480 J/cm²) spectroscopic assessments demonstrated a statistically significant decrease in persistent pigment darkening and delayed tanning post-PLE. In addition, there was a significant decrease in cyclooxygenase-2, and a trend towards decreases in the markers for cellular damage post-PLE. While there was a trend towards lower IGA scores post-PLE, statistical significance was not reached possibly due to lack of sensitivity of the visual IGA scoring system in detecting small changes. CONCLUSIONS: Spectroscopic data and immunohistochemistry indicate an effect of PLE on visible light induced effects. As such, PLE may be used as an adjuvant to traditional means of photoprotection to protect against the effects of VL. Clinical trial registration number: NCT02904798. J Drugs Dermatol. 2019;18(12):1198-1203.


Asunto(s)
Hiperpigmentación/prevención & control , Extractos Vegetales/farmacología , Polypodium/química , Pigmentación de la Piel/efectos de los fármacos , Administración Oral , Ciclooxigenasa 2/metabolismo , Femenino , Humanos , Luz , Masculino , Extractos Vegetales/administración & dosificación , Pigmentación de la Piel/efectos de la radiación
20.
J Drugs Dermatol ; 17(9): 1010-1013, 2018 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-30235390

RESUMEN

Microneedling was first described in 1995 by Orentreich and Orentreich for the treatment of atrophic scars and wrinkles.1 The local injury induced by dermal penetration of microneedling causes release of growth factors such as transforming growth factor (TGF)-α, TGF-ß, and platelet-derived growth factor (PDGF). This stimulates collagen and elastin fiber production as well as capillary formation, ultimately leading to tissue remodeling.2.


Asunto(s)
Cicatriz/cirugía , Técnicas Cosméticas/instrumentación , Ritidoplastia/instrumentación , Envejecimiento de la Piel , Cicatriz/patología , Electricidad , Humanos , Agujas , Ondas de Radio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA